One of health insurers' policy priorities this year will be defending their ability to raise questions about doctors' treatment decisions, according Matt Eyles, the president of America's Health Insurance Plans.
"We're going to push back on restrictions on evidence-based medical management, which is a critical tool to support health insurance providers' efforts to prioritize treatments that work, that are high-quality, proven and affordable," Eyles said last week, during an AHIP State of the Industry web presentation.
Controlling the underlying cost of care is critical to ensuring that more Americans have access to affordable coverage and care, Eyles said.
Eyles said AHIP will also continue to fight pharmaceutical companies' efforts to increase drug prices, by using strategies to shut out competition from generic drugs and other competing drugs.
